Search results

• 2022

  Randomised controlled trial of the short-term effects of OROS-methylphenidate on ADHD symptoms and behavioural outcomes in young male prisoners with attention deficit hyperactivity disorder: CIAO-II study

  Asherson, P., Johansson, L., Holland, R., Bedding, M., Forrester, A., Laura, G., Ginsberg, Y., Howitt, S., Kretzschmar, I., Lawrie, S., Marsh, C., Kelly, C., Mansfield, M., McCafferty, C., Khan, K., Muller-Sedgwick, U., Strang, J., Williamson, G., Wilson, L., Young, S., & 2 othersLandau, S. & Thomson, L., 3 Jun 2022, In: British Journal of psychiatry. p. 1 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Methylphenidate 100%
  • Osmotic Controlled-Release Oral Delivery System 100%
  • Randomized Controlled Trial 100%
  • Reduction (Chemistry) 50%
  6 Citations (Scopus)

  69 Downloads (Pure)